Having trouble accessing articles? Reset your cache.

Aldoxorubicin: Phase IIb ongoing

CytRx said a data safety monitoring committee recommended continuation of an open-label, international Phase IIb trial comparing aldoxorubicin vs.

Read the full 197 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE